These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29680171)

  • 21. Contemporary transcatheter aortic valve replacement with third-generation balloon-expandable versus self-expanding devices.
    Rogers T; Steinvil A; Buchanan K; Alraies MC; Koifman E; Gai J; Torguson R; Okubagzi P; Ben-Dor I; Pichard A; Satler L; Waksman R
    J Interv Cardiol; 2017 Aug; 30(4):356-361. PubMed ID: 28493389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Procedural and thirty-day outcomes following transfemoral implantation of the fully repositionable and retrievable Lotus valve without routine pre-dilatation in a consecutive patient cohort: a single-center experience.
    Ruparelia N; Thomas K; Newton JD; Grebenik K; Keiralla A; Krasopoulos G; Sayeed R; Banning AP; Kharbanda RK
    Cardiovasc Revasc Med; 2018; 19(1 Pt B):78-82. PubMed ID: 29137967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery.
    Popma JJ; Adams DH; Reardon MJ; Yakubov SJ; Kleiman NS; Heimansohn D; Hermiller J; Hughes GC; Harrison JK; Coselli J; Diez J; Kafi A; Schreiber T; Gleason TG; Conte J; Buchbinder M; Deeb GM; Carabello B; Serruys PW; Chenoweth S; Oh JK;
    J Am Coll Cardiol; 2014 May; 63(19):1972-81. PubMed ID: 24657695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First experience with transfemoral transcatheter aortic valve implantation without prior balloon pre-dilatation using a latest generation repositionable and retrievable transcatheter heart valve†.
    Schaefer A; Harmel E; Seiffert M; Reichart D; Deuschl F; Schofer N; Schneeberger Y; Blankenberg S; Reichenspurner H; Schaefer U; Conradi L
    Interact Cardiovasc Thorac Surg; 2017 May; 24(5):659-662. PubMed ID: 28329312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regression of Paravalvular Aortic Regurgitation and Remodeling of Self-Expanding Transcatheter Aortic Valve: An Observation From the CoreValve U.S. Pivotal Trial.
    Oh JK; Little SH; Abdelmoneim SS; Reardon MJ; Kleiman NS; Lin G; Bach D; Gillam L; Kar B; Coselli J; Sengupta PP; Grewal K; Chang J; Chang Y; Boulware M; Adams DH; Popma JJ;
    JACC Cardiovasc Imaging; 2015 Dec; 8(12):1364-1375. PubMed ID: 26508386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence, indications and predicting factors of permanent pacemaker implantation after transcatheter aortic valve implantation: A retrospective study.
    Becker M; Blangy H; Folliguet T; Villemin T; Freysz L; Luc A; Maureira P; Popovic B; Olivier A; Sadoul N
    Arch Cardiovasc Dis; 2017 Oct; 110(10):508-516. PubMed ID: 28647466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1-Year Results in Patients Undergoing Transcatheter Aortic Valve Replacement With Failed Surgical Bioprostheses.
    Deeb GM; Chetcuti SJ; Reardon MJ; Patel HJ; Grossman PM; Schreiber T; Forrest JK; Bajwa TK; O'Hair DP; Petrossian G; Robinson N; Katz S; Hartman A; Dauerman HL; Schmoker J; Khabbaz K; Watson DR; Yakubov SJ; Oh JK; Li S; Kleiman NS; Adams DH; Popma JJ
    JACC Cardiovasc Interv; 2017 May; 10(10):1034-1044. PubMed ID: 28521921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Permanent pacing after transcatheter aortic valve implantation of a CoreValve prosthesis as determined by electrocardiographic and electrophysiological predictors: a single-centre experience.
    Kostopoulou A; Karyofillis P; Livanis E; Thomopoulou S; Stefopoulos C; Doudoumis K; Theodorakis G; Voudris V
    Europace; 2016 Jan; 18(1):131-7. PubMed ID: 26060209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Four-year durability of clinical and haemodynamic outcomes of transcatheter aortic valve implantation with the self-expanding CoreValve.
    Gulino S; Barbanti M; Deste W; Immè S; Aruta P; Bottari V; Benvenuto E; Tamburino C; Di Landro A; Liberto D; Santonoceto L; Sicuso R; Di Stefano D; Todaro D; Di Simone E; Indelicato A; Giannazzo D; Sgroi C; Tamburino C
    EuroIntervention; 2016 Oct; 12(8):e1031-e1038. PubMed ID: 26485733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. One-year outcomes after direct transcatheter aortic valve implantation with a self-expanding bioprosthesis. A two-center international experience.
    Toutouzas K; Latsios G; Stathogiannis K; Drakopoulou M; Synetos A; Sanidas E; Mastrokostopoulos A; Trantalis G; Kaitozis O; Lazaros G; Yuecel S; Gerckens U; Grube E; Tousoulis D
    Int J Cardiol; 2016 Jan; 202():631-5. PubMed ID: 26451789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of permanent pacemaker requirement after transcatheter aortic valve implantation: insights from a Brazilian registry.
    Gensas CS; Caixeta A; Siqueira D; Carvalho LA; Sarmento-Leite R; Mangione JA; Lemos PA; Colafranceschi AS; Caramori P; Ferreira MC; Abizaid A; Brito FS;
    Int J Cardiol; 2014 Aug; 175(2):248-52. PubMed ID: 24880480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors for permanent pacemaker requirement after transcatheter aortic valve implantation with the CoreValve bioprosthesis.
    Jilaihawi H; Chin D; Vasa-Nicotera M; Jeilan M; Spyt T; Ng GA; Bence J; Logtens E; Kovac J
    Am Heart J; 2009 May; 157(5):860-6. PubMed ID: 19376312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depth of valve implantation, conduction disturbances and pacemaker implantation with CoreValve and CoreValve Accutrak system for Transcatheter Aortic Valve Implantation, a multi-center study.
    Lenders GD; Collas V; Hernandez JM; Legrand V; Danenberg HD; den Heijer P; Rodrigus IE; Paelinck BP; Vrints CJ; Bosmans JM
    Int J Cardiol; 2014 Oct; 176(3):771-5. PubMed ID: 25147076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conduction Abnormalities and Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement Using the Repositionable LOTUS Device: The United Kingdom Experience.
    Rampat R; Khawaja MZ; Hilling-Smith R; Byrne J; MacCarthy P; Blackman DJ; Krishnamurthy A; Gunarathne A; Kovac J; Banning A; Kharbanda R; Firoozi S; Brecker S; Redwood S; Bapat V; Mullen M; Aggarwal S; Manoharan G; Spence MS; Khogali S; Dooley M; Cockburn J; de Belder A; Trivedi U; Hildick-Smith D
    JACC Cardiovasc Interv; 2017 Jun; 10(12):1247-1253. PubMed ID: 28641846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two-Year Outcomes in Patients With Severe Aortic Valve Stenosis Randomized to Transcatheter Versus Surgical Aortic Valve Replacement: The All-Comers Nordic Aortic Valve Intervention Randomized Clinical Trial.
    Søndergaard L; Steinbrüchel DA; Ihlemann N; Nissen H; Kjeldsen BJ; Petursson P; Ngo AT; Olsen NT; Chang Y; Franzen OW; Engstrøm T; Clemmensen P; Olsen PS; Thyregod HG
    Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27296202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemodynamic and Echocardiographic Comparison of the Lotus and CoreValve Transcatheter Aortic Valves in Patients With High and Extreme Surgical Risk: An Analysis From the REPRISE III Randomized Controlled Trial.
    Asch FM; Vannan MA; Singh S; Khandheria B; Little SH; Allocco DJ; Meredith IT; Feldman TE; Reardon MJ; Weissman NJ
    Circulation; 2018 Jun; 137(24):2557-2567. PubMed ID: 29530883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-Term Outcomes of Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Kidney Transplant Recipients (from the US Nationwide Representative Study).
    Abdelfattah OM; Saad AM; Abushouk A; Hassanein M; Isogai T; Gad MM; Ahuja KR; Yun J; Krishnaswamy A; Kapadia S
    Am J Cardiol; 2021 Apr; 144():83-90. PubMed ID: 33383014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Balloon Post-Dilation Following Implantation of a Self-Expanding Transcatheter Aortic Valve Bioprosthesis.
    Harrison JK; Hughes GC; Reardon MJ; Stoler R; Grayburn P; Hebeler R; Liu D; Chang Y; Popma JJ;
    JACC Cardiovasc Interv; 2017 Jan; 10(2):168-175. PubMed ID: 28104211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2-year results of CoreValve implantation through the subclavian access: a propensity-matched comparison with the femoral access.
    Petronio AS; De Carlo M; Bedogni F; Maisano F; Ettori F; Klugmann S; Poli A; Marzocchi A; Santoro G; Napodano M; Ussia GP; Giannini C; Brambilla N; Colombo A
    J Am Coll Cardiol; 2012 Aug; 60(6):502-7. PubMed ID: 22726631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term clinical impact of permanent cardiac pacing after transcatheter aortic valve implantation with the CoreValve prosthesis: a single center experience.
    López-Aguilera J; Segura Saint-Gerons JM; Sánchez Fernández J; Mazuelos Bellido F; Pan Álvarez-Ossorio M; Suárez de Lezo J; Romero Moreno M; Ojeda Pineda S; Pavlovic D; Mesa Rubio D; Rodriguez Diego S; Ferreiro C; Durán E; Chavarría J; Moya González J; Suárez de Lezo J
    Europace; 2018 Jun; 20(6):993-1000. PubMed ID: 28472387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.